Follow
Benjamin Di Cara
Benjamin Di Cara
IdRS - Neuropsychiatry - Pole Of Innovative Therapeutics
Verified email at fr.netgrs.com
Title
Cited by
Cited by
Year
Selective blockade of dopamine D3 versus D2 receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and …
MJ Millan, B Di Cara, A Dekeyne, F Panayi, L De Groote, D Sicard, ...
Journal of neurochemistry 100 (4), 1047-1061, 2007
1432007
Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA)
B Di Cara, R Maggio, G Aloisi, JM Rivet, EG Lundius, T Yoshitake, ...
Journal of Neuroscience 31 (47), 16928-16940, 2011
962011
The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl) 1-(indan-2-yl) piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined …
MJ Millan, A Gobert, S Roux, R Porsolt, A Meneses, M Carli, B Di Cara, ...
Journal of Pharmacology and Experimental Therapeutics 311 (1), 190-203, 2004
822004
Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in rats
B Di Cara, F Panayi, A Gobert, A Dekeyne, D Sicard, L De Groote, ...
International Journal of Neuropsychopharmacology 10 (3), 383-399, 2007
732007
Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of α2A-adrenoceptors: a dialysis comparison to talipexole and …
A Gobert, B Di Cara, L Cistarelli, MJ Millan
Journal of Pharmacology and Experimental Therapeutics 305 (1), 338-346, 2003
642003
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole
MJ Millan, B Di Cara, M Hill, M Jackson, JN Joyce, J Brotchie, S McGuire, ...
Journal of Pharmacology and Experimental Therapeutics 309 (3), 921-935, 2004
552004
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological …
A Dekeyne, M Brocco, F Loiseau, A Gobert, JM Rivet, B Di Cara, ...
Journal of Pharmacology and Experimental Therapeutics 340 (3), 765-780, 2012
322012
Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and …
A Gobert, M Brocco, A Dekeyne, B Di Cara, G Bouchez, F Lejeune, ...
Neuropsychopharmacology 34 (4), 1039-1056, 2009
302009
The melanin-concentrating hormone1 receptor antagonists, SNAP-7941 and GW3430, enhance social recognition and dialysate levels of acetylcholine in the …
MJ Millan, A Gobert, F Panayi, JM Rivet, A Dekeyne, M Brocco, JC Ortuno, ...
International Journal of Neuropsychopharmacology 11 (8), 1105-1122, 2008
282008
Serotonin depletion produces long lasting increase in striatal glutamatergic transmission
B Di Cara, N Dusticier, C Forni, JC Lievens, A Daszuta
Journal of neurochemistry 78 (2), 240-248, 2001
272001
Serotonergic regulation of the GABAergic transmission in the rat basal ganglia
B Di Cara, D Samuel, P Salin, L Kerkerian‐Le Goff, A Daszuta
Synapse 50 (2), 144-150, 2003
212003
Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer’s disease
L Peris, J Parato, X Qu, JM Soleilhac, F Lanté, A Kumar, ME Pero, ...
Brain 145 (7), 2486-2506, 2022
202022
S41744, a dual neurokinin (NK) 1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: a comparison to aprepitant (MK869) and …
MJ Millan, A Dekeyne, A Gobert, CM la Cour, M Brocco, JM Rivet, ...
European Neuropsychopharmacology 20 (9), 599-621, 2010
172010
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization
MJ Millan, CM la Cour, B Chanrion, DS Dupuis, B Di Cara, V Audinot, ...
Journal of Pharmacology and Experimental Therapeutics 340 (3), 750-764, 2012
132012
S33138, a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioural characterisation …
MJ Millan, P Svenningson, CR Ashby, M Hill, M Egeland, A Dekeyne, ...
Journal of Pharmacology and Experimental Therapeutics, 2007
122007
Blockade of dopamine D3 receptors enhances frontocortical cholinergic transmission and cognitive function in rats
A Dekeyne, B Di Cara, A Gobert, MJ Millan
Am Soc Neurosci 29 (776.4), 2004
122004
The role of microdialysis in drug discovery: focus on antipsychotic agents
MJ Millan, F Panayi, JM Rivet, B Di Cara, L Cistarelli, R Billiras, ...
Handbook of Behavioral Neuroscience 16, 485-511, 2006
82006
Trace amine-associated receptor 1 contributes to diverse functional actions of O-Phenyl-Iodotyramine in mice but not to the effects of Monoamine-based antidepressants
I Mantas, MJ Millan, B Di Cara, L Groenink, S Veiga, L Cistarelli, M Brocco, ...
International Journal of Molecular Sciences 22 (16), 8907, 2021
62021
P. 1.221 Actions of the selective melanin concentrating hormone 1 receptor antagonist,(+) SNAP-7941, in models of potential antidepressant and anxiolytic activity in rodents
MJ Millan, A Dekeyne, A Gobert, B Di Cara, V Audinot, D Cussac, ...
European Neuropsychopharmacology, S268, 2003
52003
Impaired α-tubulin re-tyrosination leads to synaptic dysfunction and is a feature of Alzheimer’s disease
L Peris, X Qu, JM Soleilhac, J Parato, F Lanté, A Kumar, ME Pero, ...
bioRxiv, 2021.05. 17.443847, 2021
22021
The system can't perform the operation now. Try again later.
Articles 1–20